SOLVIUM-HOLDING-AG
Under the motto: “We understood and are becoming sustainable”, Solvium Holding AG has issued a sustainability report. Solvium is one of the first companies in the real asset investment sector to present such a report, which is geared to the UN’s 17 Sustainable Development Goals (SDGs). The company sees itself as an actively shaping part of the economy and society. The declared goal is to make a sustainable contribution to a fairer and cleaner world as a medium-sized company.
In 2021, employees and board members almost simultaneously suggested thinking about strategies for more sustainability in the company. Shortly thereafter, the company launched a sustainability process aligned with the United Nations Sustainable Development Goals (SDGs) and the EU taxonomy with its ESG criteria. In the same year, Solvium was accepted as a member of the German Sustainable Investment Forum (Forum Nachhaltige Geldanlagen – FNG). The sustainability report now prepared is the basis for the German Sustainability Code (GSC) checklist for non-financial reporting (CSR Directive Implementation Act – CSR-RUG). Solvium will update this report annually and report on status and progress.
In 2022, Solvium Group began to align the company with society’s increased requirements for sustainable and responsible business. In order to be prepared for future legal requirements at an early stage, various data in the area of CSR have already been and are being collected and gradually integrated into risk management.
André Wreth, CMO of Solvium Holding AG: “All of us, board members and employees, have understood that there is more to CSR than just buying recycled paper and green electricity, as it is sometimes derisively called. Because our working world is also part of the world we live in and we have to make sure that we deal with each other in a sustainable, fair and responsible way. What we live inside, we also carry outside: We have added the pillar “sustainability” to our investment concept consisting of the three pillars “return, security and availability” in order to comply with our own moral and ethical as well as legal requirements. Wherever possible, we want to give equal priority to economy and ecology in the future.”
The sustainability report can be downloaded here: https://www.solvium-holding.ag/fileadmin/user_upload/SUSTAINABILITY_REPORT_2023_230405.pdf
www.solvium-holding.ag
About Solvium Holding AG
The Solvium Group is a provider and manager of sound and innovative investments for private and professional investors in the logistics sector and is an international asset manager in this field. Solvium invests in lucrative equipment such as standard containers, standard tank containers, swap bodies and freight wagons used in the international movement of goods by rail, road and the world’s oceans. In its investment products, Solvium favors tangible asset investments with short and medium terms and takes care to make the risks controllable when managing the assets. The company thus offers investors the opportunity to profit from the steadily growing logistics and transport market.
Solvium has an impeccable track record since its foundation in 2011. The company manages around 20,000 closed contracts in Germany and has invested more than 500 million Euros in investment capital to date. All rent, interest and repayments, now more than 300 million Euros, have been made on schedule and on time. Currently, the group manages assets worth more than 300 million Euros.
The group of companies includes the container manager Noble Container Leasing Ltd. with locations in Hong Kong, Singapore, Shanghai and Seoul, among others – one of the leading intra-Asian rental companies for containers – and Axis Intermodal Deutschland GmbH, Europe’s largest rental company for swap bodies.
Important notes
This press release is considered a marketing communication and is for information purposes only. It does not claim to be complete. It does not constitute investment advice, investment recommendation/financial analysis or an offer to purchase an investment product.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230420005502/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
30 Peer-Reviewed Studies Highlight Statistically Significant Health Benefits of Almased16.7.2025 09:15:00 CEST | Press release
Two recent, peer-reviewed clinical studies have found that Almased, a high-protein, low-glycemic meal replacement, delivers significant health benefits ranging from weight loss and improved metabolic health to anti-aging effects and enhanced quality of life. Both reviews synthesize 30 peer-reviewed clinical studies across three decades of scientific research, confirming that Almased is effective and safe for weight reduction, preservation of lean muscle mass, and cardiovascular health. The 2025 review in the American Journal of Biomedical Science & Research highlighted Almased’s efficacy and safety for wide groups of people including individuals seeking weight loss, those with metabolic syndrome or fatty liver, older adults needing to preserve muscle mass, and athletes or healthy-weight individuals who require additional high-quality protein. This review also discusses how Almased’s patented fermentation process produces over 80 bioactive peptides, including 2 times the average daily i
The Future of Connectivity Starts Here: Network X Returns to Paris October 14 - 1616.7.2025 09:00:00 CEST | Press release
Show Reconvenes at Paris Expo Porte de Versailles with Global Representation of Industry Leaders and Telco Experts Network X 2025 - the only event that brings the fixed and mobile markets together - returns to Paris Expo Porte de Versailles October 14 - 16. Built for telecom's top players, this annual show drives business model innovation and monetisation of next-generation fixed, mobile, satellite and transport networks through AI and cloud. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250716595903/en/ Speaker on Headliners Stage at Network X 2024 New to Network X in 2025 are specialty events designed to deliver expert insights on trending topics including Data Center World and two Expo Stages for Fixed-Line and Mobile. More than 5,500 telco network infrastructure professionals will gather alongside 1,500 telcos to learn from six program tracks highlighting the latest advancements in Fibre, Wi-Fi Networks and Services, IP
Skechers AERO Series Opens New Chapter of Technical Running Innovation16.7.2025 09:00:00 CEST | Press release
New Collection Features an Evolution in Design that Cuts Through the Wind for That Aerodynamic Feel on Every Run Skechers Performance opens a new chapter of running innovation with the arrival of the Skechers AERO series. Named for the aerodynamic feel of the design, Skechers AERO represents the latest evolution of technical running shoes from the brand. The collection is engineered to deliver an exhilarating blend of speed, style and comfort to help runners cut through the wind and push beyond their personal bests while logging miles. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250716754749/en/ Introducing the Skechers AERO Series of technical running shoes: Skechers AERO Burst, Skechers AERO Spark, and Skechers AERO Tempo (L-R). “Recently launched in North America and Asia, the AERO Series leverages innovative technologies to elevate our signature comfort that’s now available to runners in Europe,” said Ben Stewart, Vic
4Moving Biotech Enrolls First Patient in Phase 2a Trial of 4P004, a Potential First-in-Class GLP-1 Therapy for Knee Osteoarthritis16.7.2025 07:00:00 CEST | Press release
- First patient enrolled in INFLAM MOTION, a global randomized Phase 2a trial including 129 knee osteoarthritis patients - 4P004 to be evaluated over 3 months for dual efficacy: symptom relief and synovial health improvement via contrast-enhanced MRI - Topline results expected in the second half of 2026 4Moving Biotech (4MB), a spin-off of 4P-Pharma dedicated to developing first-in-class treatments that modify the natural course of knee osteoarthritis (OA), today announced that the first patient has been enrolled in Phase 2a clinical trial, INFLAM MOTION. The study will evaluate 4P004, an intra-articular GLP-1 analog, as a potential first-in-class therapeutic candidate for knee osteoarthritis. INFLAM MOTION is a multicenter, randomized, double-blind, placebo-controlled Phase 2a trial planned to be conducted across Europe, the United States, and Canada. A total of 129 patients worldwide diagnosed with knee OA will be enrolled to evaluate, for the first time in humans, the efficacy of 4P
Belkin Achieves Qi2.2 Certification for Its Upcoming Products, Unlocking the Future of 25W Wireless Charging15.7.2025 19:06:00 CEST | Press release
With Qi2.2 certification, Belkin reinforces its commitment to quality, safety, and performance for the next generation of wireless charging Belkin, a leading consumer electronics brand for over 40 years, today announced it has received official Qi2.2 certification from the Wireless Power Consortium (WPC) for its upcoming products. As one of the first accessory brands to deliver Qi2.2-certified devices, Belkin is helping bring the next generation of wireless charging to market – enabling faster wireless charging speeds, broader compatibility, and improved performance for consumers. Belkin’s close partnership with the WPC since 2015 has been instrumental in bringing these advancements to consumers. As an early adopter and long-time contributor to WPC standards, Belkin was selected as one of a small group of trusted manufacturers to test and certify Qi2.2 products ahead of the broader industry rollout. All Belkin products undergo rigorous safety, quality, and performance testing. The comp
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom